Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

NCT04349436

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Cancer, +23 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

NCT05352672

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations
  • UC San Diego La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Seidman Cancer Center Cleveland, Ohio, United States
View all 210 locations
View Trial Details
Active, Not Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

NCT07288203

Conditions
Melanoma, Melanoma (Skin Cancer), Metastatic Melanoma, +12 more
Locations
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Greenslopes Private Hospital Greenslopes, Queensland, Australia
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada, Canada
  • Centre Hospitalier de l'Universite de Montreal Montral, Quebec, Canada, Canada
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

NCT03157128

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Any Solid Tumor, +46 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 85 locations
View Trial Details

Related conditions